Skip to main content
SpringerLink
Log in

Using serum prealbumin concentration to monitor risk in end-stage renal disease patients

  • Research Highlight
  • Published:

From Nature Clinical Practice Nephrology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Kate Matthews
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matthews, K. Using serum prealbumin concentration to monitor risk in end-stage renal disease patients. Nat Rev Nephrol 2, 60–61 (2006). https://doi.org/10.1038/ncpneph0079

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0079

  • Springer Nature Limited

Search

Navigation